North America oligonucleotides synthesis market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026

Market Segmentation:
By Product Type (DNA Oligonucleotides, RNA Oligonucleotides), Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos), Consumables (Instruments, Kits & Reagents, Others), Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis), Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others), End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others), Country (U.S., Canada, Mexico)

Some of the major factors contributing to the growth of North America oligonucleotides synthesis market:
> High prevalence rate of obese population in U.S.
> Increasing R&D expenditure in pharmaceutical and biotechnology companies and rise in venture investments

Market Players:

The key market players for North America oligonucleotides synthesis market are listed below:

> Agilent Technologies, Inc.
> Atdbio Ltd.
> LGC Limited
> Bio-Synthesis Inc.
> Eurofins Genomics
> Kaneka Eurogentec S.A.
> General Electric
> Genscript
> AJINOMOTO CO., INC (Genedesign, Inc.)
> Danaher
> Merck Kgaa
> Lgc Biosearch Technologies
> Nitto Denko
> Thermo Fisher Scientific
> Trilink Biotechnologies, Llc
> Biolytic Lab Performance Inc.
> Polygen Gmbh
> Quintara Biosciences
> Bio Basic Inc.
> Danaher (Integrated DNA Technologies, Inc)
> Twist Bioscience
> Others